ChroMedX Corp. is a medical technology company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing. The Company's devices are protected by issued US and pending international patents, dealing with blood collection, analysis and plasma/serum processing.

ChroMedX Corp. is a Canadian corporation with its head office located in Toronto, Ontario.  The Company commenced operations and trading publicly in July 2014.